« Back to Record
Risi, E., Biagioni, C., Benelli, M., Migliaccio, I., McCartney, A., Bonechi, M., Guarducci, C., Hilbers, F. F., Di Cosimo, S., Huober, J., Romagnoli, D., Boccalini, G., Vitale, S., Sotiriou, C., Biganzoli, L., Di Leo, A., & Malorni, L. (2019). An RB-1 loss of function gene signature as a tool to predict response to neoadjuvant chemotherapy plus anti-HER2 agents: a substudy of the NeoALTTO trial (BIG 1-06). Therapeutic advances in medical oncology, 11. doi:10.1177/1758835919891608
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/298688



